Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 90, Issue 4, Pages 625-629
Publisher
Springer Nature
Online
2011-09-07
DOI
10.1038/clpt.2011.185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
- (2013) Mark H. Eckman ANNALS OF INTERNAL MEDICINE
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Warfarin Dosing
- (2011) Brian S. Finkelman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- National Estimates of Emergency Department Visits for Hemorrhage-Related Adverse Events From Clopidogrel Plus Aspirin and From Warfarin
- (2010) Nadine Shehab et al. ARCHIVES OF INTERNAL MEDICINE
- In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes
- (2010) U. Nowak-Gottl et al. BLOOD
- Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
- (2010) N. A. Limdi et al. BLOOD
- Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing
- (2010) P Lenzini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Warfarin Genotyping Reduces Hospitalization Rates
- (2010) Robert S. Epstein et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy
- (2009) N. S. FERDER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Warfarin Pharmacogenetics: CYP2C9 and VKORC1 Genotypes Predict Different Sensitivity and Resistance Frequencies in the Ashkenazi and Sephardi Jewish Populations
- (2008) Stuart A. Scott et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The largest prospective warfarin-treated cohort supports genetic forecasting
- (2008) M. Wadelius et al. BLOOD
- Pharmacology and Management of the Vitamin K Antagonists
- (2008) Jack Ansell et al. CHEST
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
- (2008) BF Gage et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis
- (2008) Jonatan D. Lindh et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now